Cardiac amyloidosis (CA) is a rare but potentially life-threatening disease in which misfolded
proteins accumulate in the cardiac wall tissue. Heart rhythm disorders in CA, including …

Cardiac sarcoidosis is an inflammatory myocardial disease of unknown etiology. It is
characterized by the deposition of non-caseating granulomas that may involve any part of …

Background Coronary artery calcium (CAC) is a marker of plaque burden. Whether CAC
improves risk stratification for incident sudden cardiac death (SCD) beyond atherosclerotic …

Sarcoidosis is a multisystem inflammatory disorder of unknown cause characterized by the
presence of nonnecrotizing granulomas. Sarcoidosis affecting the heart, termed cardiac …

Introduction Data on utilization, major complications, and in‐hospital mortality of catheter
ablation (CA) for sarcoidosis‐related ventricular tachycardia (VT) are limited. We sought to …

Background Although a coronary artery calcium (CAC) of≥ 1,000 is a subclinical
atherosclerosis threshold to consider combination lipid-lowering therapy, differentiating very …

High CAC burden is an important risk factor for SCD in asymptomatic middle-aged adults,
suggesting that SCD risk stratification can begin in the early stages of CHD via …

Background Sarcoidosis is associated with a poor prognosis. There is a lack of data
examining the outcomes and readmission rates of sarcoidosis patients with heart failure …

Objective Sudden cardiac death (SCD) is the major cause of death in cardiac sarcoidosis
(CS). We aimed to identify the prognostic markers for sustained ventricular tachycardia (sVT) …

Cardiac amyloidosis, a condition characterized by abnormal protein deposition in the heart,
leads to restrictive cardiomyopathy and is notably associated with an increased risk of …